Comparison of predictive performance between modified Marsh propofol model and Schnider propofol model in underweight patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001502

Enrollment

Registered

2015-05-22

Start date

2013-03-20

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1. Propofol has been administered by target concentration controlled infusion in patinets undergoing elective surgery under general anesthesia. 2. A propofol pharmacokinetic model

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. body mass index (BMI) 9 (mg/dl) 3. Patients undergoing elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive urine pregnancy test 2. Patients with known hypersensitivity to propofol or to any of the excipients 3. Clinically significant impairment of cardiovascular, respiratory and renal function 4. Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.

Design outcomes

Primary

Measure	Time frame
predictive perfomrance (bias, inaccuracy, wooble divegence)	—

Secondary

Measure	Time frame
adverse events	—

Countries

Korea, Republic of

Contacts

Public ContactByungmoon Choi

Asan Medical Center

rios76@hanmail.net+82-2-3010-1704

Outcome results